Reuters logo
2 年前
BRIEF-Retrophin responds to U.S. Senate investigation on drug pricing
2015年11月4日 / 下午4点12分 / 2 年前

BRIEF-Retrophin responds to U.S. Senate investigation on drug pricing

Nov 4 (Reuters) - Retrophin Inc

* Retrophin responds to Senate investigation, spokesman says pharmaceutical pricing that strikes the right balance between affordability and innovation is of legitimate concern

* Retrophin spokesman says will work with special committee

* Retrophin focused on pipeline of promising drugs for patients with catastrophic diseases rather than on acquiring and re-marketing old therapies

* Retrophin says committed to therapies being available at minimal or no cost to patients Further company coverage: (Reporting By Caroline Humer)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below